SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Rigel Pharmaceuticals, Inc. (RIGL)
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
566 39 0 RIGL
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
291Thanks. I have yet to dig into RIGL. Too much to do. But as I posted before..kenhott-12/14/2005
290>>Am J Respir Cell Mol Biol. 2005 Dec 9; [Epub ahead of print] Syk Activtuck-12/14/2005
289Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) SOUTH SAN FRANCISCO, Calif., Dec. 7John McCarthy-12/7/2005
288No I didn't listen to the cc yet. I plan to when I get a little time. I hakenhott-12/6/2005
287Did you in fact listen to the CC? I would recommend doing so. It seems to be mtuck-12/5/2005
286I think you make some valid points re: SYK, given how the market threw RIGEL in LJM-12/1/2005
285Just looking around after the news this morning. Someone in the know should spekenhott-12/1/2005
284Thanks George. Think I'll add some here. MC is now under $200 million. Whofred hayes-12/1/2005
283the rest of the pipe is very early. the RA is in P1, but everything else is farmopgcw-12/1/2005
282Maybe I should average down here? Don't have much, and haven't looked atfred hayes-12/1/2005
281an empathetic ouch is right. Were the company's prospects widely consideredquidditch-12/1/2005
280ouch. not expected. alas.mopgcw-12/1/2005
279Press Release Source: Rigel Pharmaceuticals, Inc. Rigel Announces Disappointinrkrw-12/1/2005
278Study Published in Molecular Biology of the Cell SOUTH SAN FRANCISCO, CalifLJM-11/28/2005
277Rigel Announces Presentation of Phase I Data on R406/788 at the American Collegemopgcw-11/16/2005
276Rigel files $200 million mixed shelf offering Thu Nov 10, 2005 05:52 PM ET WASmopgcw-11/11/2005
275Rigel Announces Third Quarter 2005 Financial Results Tuesday November 8, 7:30 ammopgcw-11/9/2005
274Rigel Announces Publications Highlighting Two New Screening Mechanisms for Ubiqumopgcw-11/4/2005
273Rigel Announces Presentations at American College of Allergy, Asthma and Immunolmopgcw-11/1/2005
272Serono, Rigel Sign Pact On Aurora Kinase Inhibitors DOW JONES NEWSWIRES Octobermopgcw-10/25/2005
271[Multiple Roles for the Receptor Tyrosine Kinase Axl in Tumor Formation] >&gtuck-10/18/2005
270Studies Published in Cancer Research SOUTH SAN FRANCISCO, Calif., Oct. 18 /LJM-10/18/2005
269Rigel Announces Changes to Board of Directors and Appoints Gary A. Lyons Wednesdmopgcw-10/5/2005
268[Ubiquitin Ligase Activity of UHRF1, a Nuclear RING Finger Protein, in Tumor Celtuck-10/3/2005
267Didn't notice, but Denver is the right place to study allergies. (BTW, hekeokalani'nui-10/1/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News